Daphne Quimi
CIK 1543031 · Chief Financial Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$51.4K
Companies
3
Total Filings
59
Lifetime Open-Market Net
-$1.58M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Recent Filings · Page 2 of 6
59 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-01-13 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +29,259 | -$355.4K | EDGAR |
| 2023-01-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Tax (F) | −3,884 | -$46.7K | EDGAR |
| 2023-01-04 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +49,768 | -$287.5K | EDGAR |
| 2022-10-03 | IPSC | Grant (A) | — | $0 | EDGAR |
| 2022-09-06 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −4,397 | -$49.6K | EDGAR |
| 2022-08-09 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −5,798 | -$69.6K | EDGAR |
| 2022-06-21 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Sell (S) | −4,396 | -$39.6K | EDGAR |
| 2022-06-10 | AMLX | Grant (A) | — | $0 | EDGAR |
| 2022-01-19 | AMICUS THERAPEUTICS, INC. (FOLD) Delisted | Mixed | +17,997 | -$198.4K | EDGAR |
| 2022-01-10 | AMLX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.